Elena Simón Polo

Brain metastases from lung cancer responding to erlotinib: the importance of<i>EGFR</i>mutation

R. Porta, J.M. Sánchez-Torres, Luis Paz‐Ares et al. · European Respiratory Journal · 2010 · 317 citations · Full text

Medicine, Oncology, Pharmacology +15

Conjunctival intraepithelial and invasive squamous cell carcinomas treated with strontium-90

L. Cerezo, José Pedro Otero, G. Aragón et al. · Radiotherapy and Oncology · 1990 · 53 citations

Medicine, Oncology, Surgery +11

Individual risk of abdominal disease in patients with stages I and II supradiaphragmatic Hodgkin's disease. A rule index based on 341 laparotomized patients

GM Cruz, Higinia R. Cárdenes, J. Otero et al. · Cancer · 1990 · 25 citations

Medicine, Hematology, Pathology +14

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and &lt;3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study

Javier Sastre, Pilar García‐Alfonso, José María Viéitez et al. · ESMO Open · 2021 · 25 citations · Full text

Medicine, Oncology, Pharmacotherapy +13